Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3323-3327

  Yamada, Yasuhiro ^a   Yoshimi, Naoki ^a   Hirose, Yoshinobu ^a   Kawabata, Kunihiro ^a   Matsunaga, Kengo ^a   Shimizu, Masahito ^a   Hara, Akira ^a   Mori, Hideki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COLON CARCINOGENESIS; COLON MUCOSA; GENE MUTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; ANIMALS; AZOXYMETHANE; BETA CATENIN; CADHERINS; COLON; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; INTESTINAL MUCOSA; MALE; POINT MUTATION; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; TRANS-ACTIVATORS;

EID: 0034235011     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Vogelstein, B., Fearon, E., Hamilton, S., Kern, S., Preisinger, A., Leppert, M., Nakamura, Y., White, R., Smits, A., and Bos, J. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525-532, 1988.
2. Bird, R. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37: 147-151, 1987.
3. Bird, R. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93: 55-71, 1995.
4. Reddy, B., Rao, C., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996.
5. Shivapurkar, N., Tang, Z., Ferreira, A., Nasim, S., Garett, C., and Alabaster, O. Sequential analysis of K-ras mutations in aberrant crypt foci and colonie tumors induced by azoxymethane in Fischer-344 rats on high-risk diet. Carcinogenesis, 15: 775-778, 1994.
6. Molenaar, M., Wetering, M. V. D., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell, 86: 391-399, 1996.
7. Behrens, J., Kries, J. v., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature, 382: 638-642, 1996.
8. Korinek, V., Barker, N., Morin, P., Wichen, D. v., Weger, R. d., Kinzler, K., Vogelstein, B., and Clevers, H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science, 275: 1784-1787, 1997.
9. Wetering, M. v. d., Cavallo, R., Dooijes, D., Beest, M. v., Es, J. v., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M., and Clevers, H. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene. dTCF. Cell, 88: 789-799, 1997.
10. Jeon, S., Jeong, S., Lee, C., Kim, J., Kim, Y., Chung, H., Park, S., and Seong, R. Expression of Tcf-1 mRNA and surface TCR-CD3 complexes are reduced during apoptosis of T cells. Int. Immunol., 10: 1519-1527, 1998.
11. Young, C., Kitamura, M., Hardy, S., and Kitajewski, J. Wnt-1 induces growth, cytosolic β-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol. Cell. Biol., 18: 2474-2485, 1998.
12. Orford, K., Crockett, C., Jensen, J., Weissman, A., and Byers, S. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem., 272: 24735-24738, 1997.
13. Morin, P., Sparks, A., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
14. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., and Nakamura, Y. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet., 1: 229-233, 1992.
15. Powell, S., Zilz, N., Beazer-Barclay, Y., Bryan, T., Hamilton, S., Thibodeau, S., Vogelstein, B., and Kinzler, K. APC mutations occur early during colorectal tumorigenesis. Nature, 359: 235-237, 1992.
16. Smith, A., Stern, H., Penner, M., Hay, K., Mitri, A., Bapat, B., and Gallinger, S. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54: 5527-5530, 1994.
17. Ilyas, M., Tomlinson, I., Rowan, A., Pignatelli, M., and Bodmer, W. β-Catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. USA, 94: 10330-10334, 1997.
18. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., and Nakamura, Y. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res., 58: 2524-2527, 1998.
19. Zurawel, R., Chiappa, S., Allen, C., and Raffel, C. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res., 58: 896-899, 1998.
20. Takahashi, M., Fukuda, K., Sugimura, T., and Wakabayashi, K. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58: 42-46, 1998.
21. Filippo, C. D., Caderni, G., Bazzicalupo, M., Briani, C., Giannini, A., Fazi, M., and Dolara, P. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats. Br. J. Cancer, 77: 2148-2151, 1998.
22. Dashwood, R., Suzui, M., Nakagama, H., Sugimura, T., and Nagao, M. High frequency of β-catenin (ctnnbl) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res., 58: 1127-1129, 1998.
23. Yamada, Y., Yoshimi, N., Sugie, S., Suzui, M., Matsunaga, K., Kawabata, K., Hara, A., and Mori, H. β-Catenin (Ctnnbl) gene mutations in diethylnitrosamine (DEN)-induced liver tumors in male F344 rats. Jpn. J. Cancer Res., 90: 824-828, 1999.
24. McLellan, E., Medline, A., and Bird, R. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res., 51: 5270-5274, 1991.
25. Hamilton, S., Bussey, H., and Morson, B. En face histopathologic technic for examining colonic mucosa of resection specimens. Am. J. Clin. Pathol., 78: 514-517, 1982.
26. Suzui, M., Yoshimi, N., Dashwood, R., Ushijima, T., Sugimura, T., Mori, H., and Nagao, M. Frequent mutations in the rat β-catenin gene (Ctnnbl) of ulcerative colitis-associated colon cancer induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol. Carcinog., 24: 232-237, 1999.
27. Tetsu, O., and McCormick, F. β-Catenin regulates expression of cyclin DI in colon carcinoma cells. Nature, 398: 422-426, 1999.
28. He, T., Sparks, A., Rago, C., Hermeking, H., Zawel, L., Costa, L. d., Morin, P., Vogelstein, B., and Kinzler, K. Identification of c-MYC as a target of the APC pathway. Science (Washington DC), 281: 1509-1512, 1998.
29. Crawford, H., Fingleton, B., Rudolph-Owen, L., Goss, K., Rubinfeld, B., Polakis, P., and Matrisian, L. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene, 18: 2883-2891, 1999.